Grünewald et al [24], in a series of 51 patients with salivary duct carcinomas, reported MDM2 amplification in three patients (5.8%), as well as synchronous CDK4 and MDM2 amplification in one patient with a co-expression rate of 33.3%. Here, MDM2 is linked to salivary duct carcinoma.